ANI Pharma (NASDAQ: ANIP) announced the pricing of an underwritten public offering of $125,000,000 aggregate principal amount of its 3.00 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE